Literature DB >> 17433802

Prenatal programming of skeletal development in the offspring: effects of maternal treatment with beta-hydroxy-beta-methylbutyrate (HMB) on femur properties in pigs at slaughter age.

Marcin R Tatara1, Ewa Sliwa, Witold Krupski.   

Abstract

Alteration in fetal growth and development in response to prenatal environmental conditions such as nutrition has long-term or permanent effects during postnatal life. The aim of this study was to investigate effects of beta-hydroxy-beta-methylbutyrate (HMB) treatment of sows during the last 2 weeks of pregnancy on programming of skeletal development in the offspring. The study was performed on 141 pigs born by 12 sows of Polish Landrace breed. Two weeks before delivery, pregnant sows were divided into two groups. The first group consisted of control sows (N=6) that were treated with placebo. Sows that were orally treated with beta-hydroxy-beta-methylbutyrate (N=6) at the dosage of 0.05 g/kg of body weight per day belonged to the second group. Newborn piglets were weighed and subjected to blood collection for determination of serum levels of growth hormone (GH), insulin-like growth factor-1 (IGF-1), insulin, leptin, glucose and bone alkaline phosphatase (BAP) activity and lipid profile. At the age of 6 months, the piglets were slaughtered, their femur was isolated for analysis and assessment of lean meat content of carcasses was performed. The effects of maternal administration with HMB on skeletal properties in the offspring were evaluated in relation to bone mineral density and geometrical and mechanical properties. Maternal treatment with HMB increased serum levels of GH, IGF-1 and BAP activity in the newborns by 38.0%, 20.0% and 26.0%, respectively (P<0.01). HMB administration significantly increased volumetric bone mineral density of the trabecular and cortical bone of femur in the offspring at the age of 6 months (P<0.001). The weight of femur and geometrical parameters such as cross-sectional area, second moment of inertia, mean relative wall thickness and cortical index were significantly increased after HMB treatment (P<0.05). HMB induced higher values of maximum elastic strength and ultimate strength of femur (P<0.01). Furthermore, lean meat content of carcass was significantly increased in the females born by HMB-treated sows (P<0.05). The obtained results showed that maternal administration with HMB has positive long-term effects on bone tissue and improves volumetric bone mineral density, geometrical and mechanical properties of femur in the offspring. These effects were connected with increased level of GH and IGF-1 in the newborns indicating involvement of improved somatotrophic axis function in prenatal programming of skeletal development in pigs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433802     DOI: 10.1016/j.bone.2007.02.018

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Developmental programming: the role of growth hormone.

Authors:  Anita M Oberbauer
Journal:  J Anim Sci Biotechnol       Date:  2015-02-12

2.  Perinatal Risk Factors and Genu Valgum Conducive to the Onset of Growing Pains in Early Childhood.

Authors:  Angelos Kaspiris; Efstathios Chronopoulos; Elias Vasiliadis
Journal:  Children (Basel)       Date:  2016-11-18

3.  Transfer of β-hydroxy-β-methylbutyrate from sows to their offspring and its impact on muscle fiber type transformation and performance in pigs.

Authors:  Haifeng Wan; Jiatao Zhu; Caimei Wu; Pan Zhou; Yong Shen; Yan Lin; Shengyu Xu; Lianqiang Che; Bin Feng; Jian Li; Zhengfeng Fang
Journal:  J Anim Sci Biotechnol       Date:  2017-01-07

4.  The Effect of a 12-Week Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation on Highly-Trained Combat Sports Athletes: A Randomised, Double-Blind, Placebo-Controlled Crossover Study.

Authors:  Krzysztof Durkalec-Michalski; Jan Jeszka; Tomasz Podgórski
Journal:  Nutrients       Date:  2017-07-14       Impact factor: 5.717

5.  A metabolite of leucine (β-hydroxy-β-methylbutyrate) given to sows during pregnancy alters bone development of their newborn offspring by hormonal modulation.

Authors:  Tomasz Blicharski; Ewa Tomaszewska; Piotr Dobrowolski; Monika Hułas-Stasiak; Siemowit Muszyński
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

6.  Effects of combined maternal administration with alpha-ketoglutarate (AKG) and β-hydroxy-β-methylbutyrate (HMB) on prenatal programming of skeletal properties in the offspring.

Authors:  Marcin R Tatara; Witold Krupski; Barbara Tymczyna; Tadeusz Studziński
Journal:  Nutr Metab (Lond)       Date:  2012-05-11       Impact factor: 4.169

7.  Bone mineral density changes of lumbar spine and femur in osteoporotic patient treated with bisphosphonates and beta-hydroxy-beta-methylbutyrate (HMB): Case report.

Authors:  Marcin R Tatara; Witold Krupski; Barbara Majer-Dziedzic
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

8.  Net Absorption and Metabolism of β-Hydroxy- β-Methyl Butyrate during Late Gestation in a Pig Model.

Authors:  Liang Hu; Niels Bastian Kristensen; Uffe Krogh; Peter Kappel Theil
Journal:  Nutrients       Date:  2020-02-21       Impact factor: 5.717

9.  The effect of maternal HMB supplementation on bone mechanical and geometrical properties, as well as histomorphometry and immunolocalization of VEGF, TIMP2, MMP13, BMP2 in the bone and cartilage tissue of the humerus of their newborn piglets.

Authors:  Agnieszka Tomczyk-Warunek; Tomasz Blicharski; Jaromir Jarecki; Piotr Dobrowolski; Siemowit Muszyński; Ewa Tomaszewska; Lucio C Rovati
Journal:  PLoS One       Date:  2021-02-24       Impact factor: 3.240

10.  β-Hydroxy-β-Methylbutyrate (HMB) Supplementation Prevents Bone Loss during Pregnancy-Novel Evidence from a Spiny Mouse (Acomys cahirinus) Model.

Authors:  Ewa Tomaszewska; Janine Donaldson; Jakub Kosiński; Piotr Dobrowolski; Agnieszka Tomczyk-Warunek; Monika Hułas-Stasiak; Krzysztof Lamorski; Dorota Laskowska-Woźniak; Siemowit Muszyński; Rudolf Blicharski; Tomasz Blicharski
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.